Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1Vu4FWK
No comments:
Post a Comment